A.R.T. Advisors, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 64 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$36,000
-34.5%
12,477
-16.7%
0.00%
-33.3%
Q3 2019$55,000
-72.8%
14,977
-53.0%
0.00%
-62.5%
Q2 2018$202,000
-26.0%
31,882
-44.8%
0.01%
-27.3%
Q1 2018$273,000
+127.5%
57,775
+60.2%
0.01%
+120.0%
Q4 2017$120,000
+7.1%
36,071
-21.3%
0.01%
-16.7%
Q2 2017$112,000
+261.3%
45,843
+44.4%
0.01%
+200.0%
Q4 2016$31,000
+34.8%
31,740
+97.0%
0.00%
+100.0%
Q2 2016$23,000
-56.6%
16,110
-50.2%
0.00%
-66.7%
Q4 2015$53,000
-60.7%
32,353
-17.3%
0.00%
-40.0%
Q4 2014$135,000
-66.9%
39,123
-51.8%
0.01%
-73.7%
Q3 2014$408,00081,2240.02%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$565,0000.18%
D.A. DAVIDSON & CO. 851,101$2,604,0000.05%
Iron Gate Global Advisors LLC 17,090$52,0000.02%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$37,0000.02%
IHT Wealth Management, LLC 28,155$86,0000.01%
OSAIC HOLDINGS, INC. 1,012,430$3,098,0000.01%
Ameritas Investment Company, LLC 10,782$33,0000.01%
Vivaldi Capital Management LP 15,439$40,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$48,0000.01%
Geneos Wealth Management Inc. 37,017$108,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders